Canadian CANNAINVESTOR Magazine October 2017 - Page 13

Our name and mottos are catching on social media is filled with “CannaInvestor” characters and seems like daily we are now reading posts with “connecting the dots so you don’t have to” etc. If you think they are affiliated with us then ask us. If they are giving advice to buy or sell then it is not us and chances are what they are promoting will fall soon after. One such company promoted by a few such characters fell from $0.12 to $0.085 in the same time that our current top proprietary metrics pick (Aprhia Inc -TSX:APH) rose from $6.34 to a high of $7.23.

September has been an exciting month indeed with multiples licences granted including Canada House Wellness Group (CHV) – the day after our exclusive interview and case study. Some of our other case study companies realized gains of well over 50%. But all boats rise with the tide as the Canadian Marijuana index rose 11.11% according to meaning so long as you avoided the hucksters on social media, you likely did reasonably well. But do not get overconfident – only discipline, understanding, trusted sources, and strategy will provide the opportunity for superior ROI.

Provinces are starting to announce their distribution frameworks or are progressing in developing that framework. For those that still champion an industry other than the one that is being enacted, one might take into consideration a basic tenet of the current legal medical industry: “Cannabis is not an approved drug or medicine in Canada. The Government of Canada does not endorse the use of cannabis, but the courts have required reasonable access to a legal source of cannabis when authorized by a physician”. (SOURCE). In other words - a safe, consistent, reliable, trusted, regulated, and legal supply is paramount.

To date, all relevant and reliable sources continue to forecast a supply shortage. Investing in this industry is unique in that it is ideal for the typical Retail Investor with an appropriate risk tolerance for a portion of their investment given the pending end to prohibition and the ROI of the index since January 2015 speaks for itself despite bearish periods within. Yes - it is also ideal for the contrarian investor as there is not a legal recreational industry in Canada and most medical benefits do not cover prescriptions since “cannabis is not an approved drug or medicine in Canada” and cannabis does not have a DIN assigned. But let’s keep our eye on this very important case being heard by the Nova Scotia Court of Appeal – the outcome of which may be known before this is published.

We are always looking for content and ideas so please email us at with your proposal or direct message me on twitter and until next month, invest long and prosper as we connect the dots so you don’t have to. Turning Green into Gold is the advantage you have by subscribing.